Company intelligence / Profile preview

Link Healthcare Singapore

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

Link Healthcare specializes in providing both registered and unregistered specialty medicines, including products for clinical trials, early access, compassionate use, and for rare or unmet medical needs. Their product portfolio covers multiple indications at the commercial stage, with no proprietary clinical-stage drugs, as most products are in-market or supplied under special access programs.

Therapeutic areas: ImmunologyOtherEndocrinologyNeurologyDermatologyInfectious DiseasesPsychiatryRheumatologyOncology
Modalities: Small moleculeBiologicAntibodyProteinPeptidesHormoneImmunoglobulin
Industry: Drug Discovery Services

Partnerships

Numerous licensing and distribution agreements with pharma and biotech companies worldwide (over 40 strategic alliances for supply and distribution)

Beyond the preview

Go deeper on Link Healthcare Singapore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Link Healthcare Singapore.

Explore the full profile